S

SLS

SELLAS Life Sciences Group Inc

13.19

Jul 17 • 03:59PM ET +1.44 (12.26%)

13.34

Aftermarket • 07:59PM ET +0.15 (1.14%)

Healthcare Biotechnology USA Mid NASD

Peers: IDYA TNGX CGON RCUS NUVL BMRN KYMR RYTM INCY KRYS

| Held by: XBI VTI IWM VXF IWO VTWO VHT IWC LABU ITOT

Scroll to Statements

Index	RUT
Market Cap	2.45B
Enterprise Value	2.35B
Income	-29.46M
Sales	0.00M
Book/sh	0.59
Cash/sh	0.58
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Mar 24, 2011
Dividend Gr. 3/5Y	- -
Payout	-
Employees	13
IPO	Mar 12, 2008

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	22.27
P/C	22.89
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	17.22
Current Ratio	17.22
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-0.23
EPS next Y	-0.12
EPS next Q	-0.04
EPS this Y	16.00%
EPS next Y	40.48%
EPS next 5Y	-
EPS past 3/5Y	51.28% 34.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	41.60%
Sales Y/Y TTM	-
EPS Q/Q	26.44%
Sales Q/Q	-
Earnings	May 12 AMC
EPS/Sales Surpr.	16.67% -

Insider Own	1.21%
Insider Trans	0.00%
Inst Own	29.25%
Inst Trans	9.75%
ROA	-39.50%
ROE	-43.58%
ROIC	-27.35%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.62%
SMA50	39.53%
SMA200	167.45%
Trades

Shs Outstand	186.03M
Shs Float	183.79M
Short Float	34.45%
Short Ratio	6.78
Short Interest	63.31M
52W High	15.88 -16.92%
52W Low	1.39 848.92%
Volatility	10.47% 12.67%
ATR (14)	1.37
RSI (14)	58.09
Beta	2.47
Rel Volume	1.21
Avg Volume	9.34M
Volume	11,293,041

Perf Week	3.37%
Perf Month	75.17%
Perf Quarter	167.55%
Perf Half Y	220.92%
Perf YTD	249.87%
Perf Year	594.21%
Perf 3Y	699.39%
Perf 5Y	59.11%
Perf 10Y	-99.89%
Recom	1.00
Target Price	27.50
Prev Close	11.75
Price	13.19
Change	12.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)